Download App

Log in to access Online Inquiry
Company Overview More
Shanghai Haohai Biotechnology Co., Ltd. is a Chinese company mainly engaged in biotechnology-related business. Its business includes the production and sales of biological agents and medical hyaluronic acid, bioengineering and pharmaceutical product research and development, and the provision of related services. Its products include orthopedic products, plastic surgery and wound care products, ophthalmic products, anti-adhesion and hemostatic products and so on. Orthopedic products include sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel. Plastic surgery and wound care products include recombinant human epidermal growth factor and so on. Ophthalmic products include ophthalmic viscoelasticity and eye moisturizer. Anti-adhesion and hemostatic products include collagen sponge and so on. The company mainly operates in mainland China.
CEO: Yongtai Hou
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

06826 HAOHAI BIOTEC
33.050+1.150+3.61%
YOY
Do not show
Hide blank lines
(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Assets
Current assets
Inventory
45.83% 376.83M 39.05% 354.77M 12.02% 314.61M -8.64% 264.05M
Accounts receivable
9.3% 399.71M 10.11% 375.21M 27.03% 401.98M 39.71% 397.49M
Insurance and other receivables-current assets
123.63% 32.85M -- -- 399.84% 61.39M -- --
Advance deposits and other receivables
-- -- 35.15% 74.84M -- -- 2.71% 100.53M
Cash and equivalents
-11.46% 2.7B -6.2% 2.9B -4.31% 2.9B 1.01% 3.14B
Secured deposit
-- -- -98.8% 614K -- -- -98.77% 614K
Financial assets at fair value-current assets
-- -- -57.9% 6.38M -- -- -- --
Special items of current assets
-45.02% 12.27M -- -- -63.34% 6.14M -- --
Total current assets
-4.91% 3.59B -2.56% 3.71B 1.43% 3.79B 1.9% 3.9B
Non-current assets
Fixed assets
49.38% 794.05M -- -- 18.19% 633.68M -- --
Property, plant and equipment
-- -- 22.39% 1.2B -- -- 15.4% 1.09B
Construction in progress
-16.98% 386.92M -- -- 13.76% 490.71M -- --
Associated company interest
-- -- -20.83% 3.45M -- -- -26.75% 3.49M
Interests in Joint Venture
-- -- 4.58% 47.96M -- -- -- 45.86M
long-term investment
6.41% 52.64M -- -- 2211.88% 92.04M -- --
Financial assets at fair value-non-current assets
-- -- -- -- -- -- -- 6.46M
Other investments
-- -- -- -- -- -- -- 61.99M
Intangible assets
47.62% 842.35M 51.71% 613.4M 36% 803.23M -0.3% 423.35M
Goodwill
11.28% 429.48M 5.55% 406.9M 5.43% 404.69M 0.38% 385.54M
Deferred tax assets
79.79% 50.85M 88.48% 49.36M 9.96% 34.49M -24.69% 23.2M
Other illiquid assets
67.33% 102.54M 255.36% 130.93M 22.86% 12.52M -8.97% 11.19M
Special items of non-current assets
39.78% 49.31M 29.8% 788.74M -9.21% 39.96M 17.34% 645.21M
Total non-current assets
24.19% 3.27B 30.1% 3.24B 25.48% 3.02B 14.69% 2.7B
Total assets
7.05% 6.85B 10.35% 6.95B 10.84% 6.81B 6.76% 6.6B
Liabilities
Current liabilities
Accounts payable
72.21% 48.96M 65.04% 46.26M 199.31% 63.47M 36.99% 30.2M
Tax payable
-28.42% 19.41M -94.03% 1.26M 31.13% 34.03M 44.59% 25.8M
Other payables and accrued expenses
7.92% 229.95M 33.81% 397.33M 0.45% 214.97M 5.89% 407.57M
Short-term borrowing
-97.52% 2M -- -- -68.61% 25.37M -- --
Bank loans and overdrafts
-- -- -51.63% 42.42M -- -- -39.1% 48.54M
Special items of current liabilities
52.18% 72M -- -- 5.25% 63.76M -- --
Total current liabilities
2.33% 425.2M 12.34% 487.27M 2.06% 428.79M 1.51% 512.11M
Net current assets
-5.8% 3.16B -4.47% 3.23B 1.35% 3.37B 1.95% 3.39B
Total assets less current liabilities
7.38% 6.43B 10.2% 6.46B 11.49% 6.38B 7.23% 6.08B
Non-current liabilities
Long-term bank loan
1913.35% 9.6M 93.85% 39.49M 4546.69% 28.92M -44.37% 17.85M
Long-term accounts payable
0% 4.5M 80.22% 8.11M 0% 4.5M 0% 4.5M
Deferred tax liability
68.99% 170.73M 54.39% 157.91M 49.84% 158.29M 1.49% 109.62M
Deferred income-non-current liabilities
115.41% 8.12M 165.29% 9.4M 385.15% 10.66M 220.31% 8.53M
Provision-non-current liabilities
-- -- -- 1.77M -- -- -- --
Other non-current liabilities
-- 186.12M -- 186.12M -- -- -- --
Special items of non-current liabilities
42.56% 31.21M -- -- -6.91% 23.99M -- --
Total non-current liabilities
211.61% 410.27M 208.19% 402.8M 63.16% 226.36M -4.59% 140.49M
Total liabilities
52.68% 835.47M 57.69% 890.07M 17.23% 655.15M 0.13% 652.6M
Total assets less total liabilities
2.79% 6.02B 5.69% 6.06B 10.2% 6.16B 7.55% 5.94B
Total equity and non-current liabilities
7.38% 6.43B 10.2% 6.46B 11.49% 6.38B 7.23% 6.08B
Equity
Share capital
-0.45% 175.82M -0.78% 175.82M -0.78% 175.82M -0.69% 176.62M
Reserve
-- -- 3.67% 5.54B -- -- 7.88% 5.55B
Legal reserve
0% 88.92M 3.67% 5.54B 0% 88.92M 7.88% 5.55B
Capital reserve
-4.66% 3.08B -- -- -2.84% 3.17B -- --
Undistributed profit
14.85% 2.37B -- -- 23.69% 2.27B -- --
Special items of shareholders' rights and interests
3.74% 46.61M -- -- -103.87% -1.74M -97.92% -44.91M
Shareholders' Equity
0.17% 5.62B 4.06% 5.71B 6.56% 5.7B 7.21% 5.68B
Non-controlling interest
61.93% 402.43M 42.44% 346.83M 92.62% 456.02M 15.26% 266.34M
Total equity
2.79% 6.02B 5.69% 6.06B 10.2% 6.16B 7.55% 5.94B
Total equity and total liabilities
7.05% 6.85B 10.35% 6.95B 10.84% 6.81B 6.76% 6.6B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)IASCAS (2007)IAS
Audit Opinions
--Unqualified Opinion----
Auditor
--Ernst & Young Huaming Accounting firm (Special General Partnership)----

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%